Global live cell imaging market expected to generate around USD 3.43 billion by 2025, at a CAGR of around 8.5% between 2019 and 2025. The development of new drugs and the growing use of high content screening has further propelled the global live imaging market worldwide.
The report covers a forecast and an analysis of the live cell imaging market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the live cell imaging market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the live cell imaging market on a global as well as regional level.
In order to give the users of this report a comprehensive view of the live cell imaging market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the live cell imaging market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the live cell imaging market by segmenting it based on the product, technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players of the global live cell imaging market include Danaher Corporation, Nikon Corporation, Olympus Corporation, GE Healthcare, Bruker Corporation, Thermo Fischer Scientific, Sartorius, Etaluma, BioTek instruments, Perkin Elmer, Carl Zeiss, cytoSMART Technologies, and NanoEnTek.
This report segments the global live cell imaging market as follows:
Global Live Cell imaging Market: By Product
Global Live Cell imaging Market: By Technology
Global Live Cell imaging Market: By Application
Global Live Cell imaging Market: By End-User
Global Live Cell imaging Market: By Region
List of Figures
1. Market research process
2. Market research methodology
3. Global Live cell imaging Market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Live cell imaging Market attractiveness analysis, by Product
6. Live cell imaging Market attractiveness analysis, by Technology
7. Live cell imaging Market attractiveness analysis, by Application
8. Live cell imaging Market attractiveness analysis, by End-User
9. Live cell imaging Market attractiveness analysis, by Region
10. Company market share analysis, 2018
11. Global Live cell imaging Market revenue share by Product, 2018 and 2025
12. Global Live cell imaging Market Revenue for Instruments, 2016–2025 (USD Billion)
13. Global Live cell imaging Market Revenue for Consumables, 2016–2025 (USD Billion)
14. Global Live cell imaging Market Revenue for Software, 2016–2025 (USD Billion)
15. Global Live cell imaging Market Revenue for Services, 2016–2025 (USD Billion)
16. Global Live cell imaging Market revenue share by Technology, 2018 and 2025
17. Global Live cell imaging Market Revenue for Time Lapse microscopy, 2016–2025 (USD Billion)
18. Global Live cell imaging Market Revenue for Fluorescence recovery after photo bleaching(FRAP),2016–2025 (USD Billion)
19. Global Live cell imaging Market Revenue for High content screening(HCT), 2016–2025 (USD Billion)
20. Global Live cell imaging Market Revenue for Fluorescence resonance energy transfer(FRET), 2016–2025 (USD Billion)
21. Global Live cell imaging Market Revenue for Others, 2016–2025 (USD Billion)
22. Global Live cell imaging Market revenue share by Application, 2018 and 2025
23. Global Live cell imaging Market Revenue for Cell Biology, 2016–2025 (USD Billion)
24. Global Live cell imaging Market Revenue for Stem Cells, 2016–2025 (USD Billion)
25. Global Live cell imaging Market Revenue for Drug Discovery, 2016–2025 (USD Billion)
26. Global Live cell imaging Market revenue share by End-User, 2018 and 2025
27. Global Live cell imaging Market Revenue for Pharmaceutical and Biotechnology companies,2016–2025 (USD Billion)
28. Global Live cell imaging Market Revenue for Research institutes, 2016–2025 (USD Billion)
29. Global Live cell imaging Market Revenue for contract research organizations, 2016–2025 (USD Billion)
30. North America Live cell imaging Market Revenue, 2016–2025 (USD Billion)
31. Europe Live cell imaging Market Revenue, 2016–2025 (USD Billion)
32. Asia Pacific Live cell imaging Market Revenue, 2016–2025 (USD Billion)
33. Latin America Live cell imaging Market Revenue, 2016–2025 (USD Billion)
34. The Middle East and Africa Live cell imaging Market Revenue, 2016–2025 (USD Billion)
List of Tables
1. Live cell imaging Market: Market snapshot
2. Drivers of the Global Live cell imaging Market: Impact analysis
3. Restraints of the Global Live cell imaging Market: Impact analysis
4. North America Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
5. North America Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
6. North America Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
7. North America Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
8. The U.S. Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
9. The U.S. Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
10. The U.S. Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
11. The U.S. Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
12. Rest of North America Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
13. Rest of North America Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
14. Rest of North America Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
15. Rest of North America Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
16. Europe Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
17. Europe Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
18. Europe Live cell imaging Market Revenue, byApplication2016–2025 (USD Billion)
19. Europe Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
20. Germany Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
21. Germany Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
22. Germany Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
23. Germany Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
24. UK Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
25. UK Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
26. UK Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
27. UK Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
28. France Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
29. France Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
30. France Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
31. France Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
32. Rest of Europe Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
33. Rest of Europe Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
34. Rest of Europe Live cell imaging Market Revenue, by Application,2016–2025 (USD Billion)
35. Rest of Europe Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
36. Asia Pacific Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
37. Asia Pacific Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
38. Asia Pacific Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
39. Asia Pacific Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
40. China Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
41. China Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
42. China Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
43. China Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
44. Japan Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
45. Japan Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
46. Japan Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
47. Japan Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
48. India Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
49. India Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
50. India Live cell imaging Market Revenue, by Application,2016–2025 (USD Billion)
51. India Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
52. Rest of Asia Pacific Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
53. Rest of Asia Pacific Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
54. Rest of Asia Pacific Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
55. Rest of Asia Pacific Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
56. Latin America Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
57. Latin America Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
58. Latin America Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
59. Latin America Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
60. Brazil Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
61. Brazil Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
62. Brazil Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
63. Brazil Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
64. Rest of Latin America Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
65. Rest of Latin America Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
66. Rest of Latin America Live cell imaging Market Revenue, by Application, 2016–2025 (USD Billion)
67. Rest of Latin America Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
68. The Middle East and Africa Live cell imaging Market Revenue, by Product, 2016–2025 (USD Billion)
69. The Middle East and Africa Live cell imaging Market Revenue, by Technology, 2016–2025 (USD Billion)
70. The Middle East and Africa Live cell imaging Market Revenue, byApplication2016–2025 (USD Billion)
71. The Middle East and Africa Live cell imaging Market Revenue, by End-User, 2016–2025 (USD Billion)
Live cell imaging is the study of living cells using time lapse microscopy. The rising incidence of cancer, growing high content screening techniques use in drug discovery methods, faster diagnostic facilities, and increasing investments made in research funding have led to the growth of the global live cell imaging market.
Increasing prevalence of chronic diseases and growing demand for healthcare systems have contributed to the live cell imaging market growth globally over the last few years. Technological advancements related to drug discovery and rising number of government initiatives to fund cell-based research are also contributing to the global live cell imaging market. Increasing prevalence of cancer and other chronic diseases has led to the increasing demand for cell-based therapies requiring high content screening techniques for drug discovery applications. The development of new drugs and growing use of high content screening has further propelled the global live imaging market worldwide. However, the shortage of skilled professionals and high cost of high content screening may hinder the live cell imaging market. Alternatively, the use of live cell imaging in the field of personalized medicine is anticipated to offer new growth opportunities in the live cell imaging market over the forecast time period.
The global live cell imaging market is fragmented on the basis of product, application, technology, and end-user. Based on product, the market includes consumables, instruments, services, and software. On the basis of application, the market is categorized into cell biology, stem cells, drug discovery, and others. By technology, the market includes high content screening (HCS), time lapse microscopy, fluorescence resonance energy transfer (FRET), and fluorescence recovery after photo bleaching (FRAP). The end-user segment comprises biotechnology and pharmaceutical companies, research institutes, and contract research organizations.
North America is expected to dominate the global live cell imaging market over the forecast time period, owing to the huge government investments for developing research facilities, rising number of drug development regulations, flourishing biotechnology and pharmaceutical industries, increasing cancer cases, and various advancements witnessed in live cell imaging techniques. The European live cell imaging market is another vital region globally, due to the increasing incidence of chronic diseases, cancer, neurodegenerative disorders, and CVDs. Various upcoming projects and generous funding by the UK government in cell and developmental biology have also favored the live cell imaging market. Asia Pacific is an emerging market for live cell imaging. Japan dominated the Asia Pacific market in 2018, due to the increase in cancer prevalence and growth in the demand for cancer detection techniques. China is an upcoming market in the Asia Pacific region, owing to the rising aging population with chronic diseases and the escalating need for low-cost detection and treatment techniques.
Some key players of the global live cell imaging market include Danaher Corporation, Nikon Corporation, Olympus Corporation, GE Healthcare, Bruker Corporation, Thermo Fischer Scientific, Sartorius, Etaluma, BioTek instruments, Perkin Elmer, Carl Zeiss, cytoSMART Technologies, and NanoEnTek.
Request the coronavirus impact analysis across industries and markets
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed